Results of previous studies from our laboratory have shown that a strain of Bacteroides intermedius isolated originally from a patient with acute necrotizing ulcerative gingivitis binds and degrades human fibrinogen (M. S. Lantz, L. M. Switalski, K. S. Kornman, and M. Hook, J. Bacteriol. 163:623-628, 1985). We report that strains of Bacteroides gingivalis, an organism implicated in the etiology of several forms of periodontitis, also bind and degrade fibrinogen. The binding is rapid, reversible, saturable, and specific. The number of fibrinogen-binding sites per cell varies from 500 to 1,500 in different batches of bacteria, and the dissociation constant for the complex is on the order of 10-8 M. B. gingivalis possesses cell-associated fibrinogenolytic activity that is activated by dithiothreitol and blocked by thiol protease inhibitors. Interaction with fibrinogen may mediate colonization and establishment of these organisms in the periodontal microbiota.
Both procaryotic and eucaryotic cells bind the plasma protein fibrinogen (1) . Strains of Staphylococcus aureus, groups A and B streptococci, and platelets possess receptors that recognize specific domains on the fibrinogen molecule (3, 4, 7) . The interactions between fibrinogen and bacteria are of potential pathological significance since fibrinogen in its polymeric form may serve as a supportive matrix for bacterial colonization. In addition, fibrinogen is a dimer and can likely bind more than one bacterial cell per molecule; hence, it may also be a mediator of bacterial-bacterial adhesion. Some strains of S. aureus and a strain of Streptococcus pyogenes have been reported to possess fibrinogenolytic and fibrinolytic activity (22) . These activities might serve to provide a peptide source for bacteria and may also allow detachment from the matrix that is necessary for dissemination of infection and invasion of underlying tissue.
Black-pigmented Bacteroides species have been associated with gingivitis and periodontitis (15) . We have recently reported that Bacteroides intermedius, which has been associated with bleeding gingivitis, acute necrotizing ulcerative gingivitis, and some forms of periodontitis (5, 11, 17) , both binds and degrades human fibrinogen (9) . Bacteroides gingivalis has been associated with chronic adult periodontitis (15) and periodontal sites that have experienced recent bone loss (19) . Thus, B. gingivalis and B. intermedius demonstrate different patterns of periodontal disease association as well as metabolic diversity (10, 15) . We report here that B. gingivalis also binds and degrades human fibrinogen. In this study the interactions between a strain of B. gingivalis and human fibrinogen are characterized.
MATERIALS AND METHODS
Chemicals. Human fibrinogen (Kabi, Stockholm, Sweden) was purified and labeled with 1251 as described previously (9) . The specific activity of labeled fibrinogen was estimated at 1.3 x 106 cpm/,ug.
Bovine serum albumin, egg albumin (ovalbumin), a-acid glycoprotein (oroso-mucoid), human immunoglobulin G (IgG), and fetuin were purchased from Sigma Chemical Co. (St. Louis, Mo.). Rabbit anti-human fibrinogen IgG was prepared as described previously (9) , and fibronectin was * Corresponding author.
purified from human plasma (20 zymes before DTT and iodoacetamide were added ( Fig. 2A) .
In the absence of NEM there was virtually no 1251I-labeled material association with bacteria after incubation for 0.5 h (lane 5) or 4 h (lane 3). If NEM was included in the incubation mixture, cell-associated labeled material with migration properties similar to those of the fibrinogen chains was observed (cf. lanes 7 and 9 with lane 1, Fig. 2A ).
Furthermore, in the absence of NEM, the 1251I-fibrinogen recovered in the supernatant was much more degraded ( Fig.  2A, lanes 2 and 4) than when NEM was present in the incubation mixture ( Fig. 2A, lanes 6 and 8) . Figure 2B shows the same experiment as Fig. 2A but performed with bacteria stored at 4°C for 1 month. Regardless of the presence of NEM, all bacteria had bound what appears to be intact fibrinogen (Fig. 2B, lanes 3, 5, 7 , and 9) and no marked degradation of fibrinogen was detected in the supernatants. Figure 2C shows the same experiment as Fig. 2B , except that DTT was added to bacterial supernatants and pellets a few minutes before the samples were boiled. The addition of DTT stimulated cell-associated fibrinogen degradation, and only small fragments were associated with the cells (Fig. 2C , lanes 3 and 5). The presence of NEM partially blocked this degradation (Fig. 2C, lanes 7 and 9) . Taken together, these data suggest that B. gingivalis W possesses a fibrinogendegrading thiol protease that is inactivated by prolonged storage at 4°C but can be reactivated by DTT. The enzyme appears to remain cell associated during storage at 4°C and incubation at room temperature. It is notable that fibrinogen degradation in the supernatant fractions is, in general, not seen, although some degradation products may appear. We failed to detect fibrinogenolytic activity in culture media after bacteria were harvested (data not shown), suggesting that the enzyme remains cell associated during growth of the bacteria. Because of the variable thiol protease activity of cell preparations, all subsequent binding experiments were performed for 1 h in the presence of NEM. An active protease located on the surface of the cell also could conceivably degrade the bacterial fibrinogen-binding component. Therefore, we attempted to assess the stability of the fibrinogen-binding component by preincubating freshly harvested bacteria in the absence of thiol protease inhibitors for different periods of time. At the conclusion of these preincubations, NEM and 125I-fibrinogen were added, and the mixtures were incubated for an additional hour. The results (data not shown) indicate that bacteria preincubated in the absence of NEM for up to 3 h bound the same amount of 125I-fibrinogen as controls. Under these incubation condi- (Fig. 3 ). Preimmune rabbit IgG had no effect on binding of 121 1-fibrinogen to bacteria. These data suggest that bacteria recognize specific region(s) on the fibrinogen molecule and that accessibility of this domain to the bacterial binding component can be blocked by a ligand-specific antibody.
The binding of fibrinogen to B. gingivalis W is reversible since more than 90% of the bound 125 1-fibrinogen could be displaced from the bacteria by the subsequent addition of a large excess of unlabeled fibrinogen. When increasing amounts of 125 1-fibrinogen were added to a constant number of bacteria (Fig. 4) (1) and that all binding sites are occupied at saturation, the average number of fibrinogen-binding sites per cell in the experiment described here is 500. This number ranged from 500 to 1,500 in four different experiments in which different batches of bacterial cells were used. Scatchard analysis of the binding a Bacteria (109 cells) were incubated in the presence of competing protein (100 jig/ml) for 1 h, after which 1251-fibrinogen (5 x 104 cpm) was added to the incubation mixture. The amount of 1251I-fibrinogen that bound to the bacteria was determined as described in the text. Data are presented as mean percentages ± standard deviation of four replicate samples. data (14) (Fig. 4, insert) suggests a single binding site, and
gives an apparent Kd for the reaction of 2.7 x 10-8 M. In four experiments the apparent Kd value varied between 2.7 x 10-8 and 9.8 x 10-8 M.
DISCUSSION
We have previously reported that B. intermedius strains bind human fibrinogen and that B. gingivalis W failed to bind fibrinogen under the same experimental conditions (9) . In that study, binding of fibrinogen to B. gingivalis W was assessed in the presence of PMSF and EDTA, which are serine and metallo-protease inhibitors, respectively, both of which inhibit degradation of 125I-fibrinogen bound to B.
intermedius. The data presented in Fig. 1 suggest that B. gingivalis possesses fibrinogenolytic activity that is not inhibited by PMSF or EDTA. Therefore, it is not surprising that this organism appeared to be a nonbinder of human fibrinogen under the incubation conditions used in the previous study (9) . Fibrinogen binding by all four strains of B. gingivalis tested in the current study is readily demonstrated after prolonged storage at 4°C or in the presence of the thiol protease inhibitors NEM or pCMPS. The absence of DTTactivatable fibrinogenolytic thiol protease(s) from incubation supematant fractions of bacteria stored at 4°C for 1 month (cf. Fig. 2C, lanes 2 and 4) suggests that thiol proteolytic activity remains cell associated and is not released from bacteria during incubation. The data presented in Fig. 2 
